165671-05-6 Usage
Description
4,5-Difluoro-2-nitrobenzonitrile is a chemical compound characterized by its molecular formula C7H2F2N2O2. It is a yellow solid that is highly reactive due to the presence of both nitro and cyano groups. This versatile reactivity, along with its unique structural properties, makes it a valuable building block in the field of organic chemistry.
Uses
Used in Pharmaceutical and Agrochemical Industries:
4,5-Difluoro-2-nitrobenzonitrile is utilized as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its reactivity allows for the preparation of a wide range of organic compounds, making it a crucial component in these industries.
Used in Dye and Pigment Production:
4,5-Difluoro-2-nitrobenzonitrile is also used as a reagent in the production of various dyes and pigments. Its unique properties contribute to the development of colorants with specific characteristics for different applications.
Used in Polymer and Specialty Chemical Manufacturing:
4,5-Difluoro-2-nitrobenzonitrile finds application in the manufacturing of polymers and other specialty chemicals. Its role in these processes is significant, as it helps in creating materials with tailored properties for specific uses.
Check Digit Verification of cas no
The CAS Registry Mumber 165671-05-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,5,6,7 and 1 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 165671-05:
(8*1)+(7*6)+(6*5)+(5*6)+(4*7)+(3*1)+(2*0)+(1*5)=146
146 % 10 = 6
So 165671-05-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H2F2N2O2/c8-5-1-4(3-10)7(11(12)13)2-6(5)9/h1-2H
165671-05-6Relevant articles and documents
HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE
-
, (2011/10/05)
The present invention relates to compounds and methods which may be useful as inhibitors of H1R and/or H4R for the treatment or prevention of inflammatory, autoimmune, allergic, and ocular diseases.
